United Therapeutics (UTHR) awards RSUs and stock options to director
Rhea-AI Filing Summary
United Therapeutics granted director Linda Maxwell annual non-employee director equity awards on 2026-07-22, consisting of 380 restricted stock units and 1,190 stock options on common stock. The options carry a $527.0700 exercise price and expire on 2033-07-22.
Each restricted stock unit represents one share of common stock after vesting and has no expiration date. Both awards become fully vested on the earlier of one year from grant or the anticipated June 25, 2027 Annual Meeting of Shareholders. No sales or dispositions were reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
MAXWELL LINDA
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F1, F2, F3, F4 | 380 | $0.00 | $0.00 |
| Grant/Award | Stock Option F2, F3 | 1,190 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 380 shares (Direct);
Stock Option — 1,190 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2. Annual non-employee director award.
- F3. Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
- F4. Not applicable as restricted stock units do not have an expiration date.
Key Figures
Restricted stock units granted: 380 units
Stock options granted: 1190 options
Option exercise price: $527.0700 per share
+4 more
7 metrics
Restricted stock units granted
380 units
Annual non-employee director award to Linda Maxwell on 2026-07-22
Stock options granted
1190 options
Annual non-employee director award to Linda Maxwell on 2026-07-22
Option exercise price
$527.0700 per share
Exercise price for 1,190 stock options on United Therapeutics common stock
RSU underlying shares
380 shares
Each restricted stock unit represents one share of common stock after vesting
Option underlying shares
1190 shares
Common shares underlying the stock options granted to Linda Maxwell
Vesting reference date
June 25, 2027
Anticipated date of the next Annual Meeting of Shareholders used in vesting condition
Option expiration date
2033-07-22
Scheduled expiration date of the stock options if not exercised
Key Terms
Restricted Stock Unit, Stock Option, exercise price, Annual non-employee director award, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the right to receive, following vesting"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option financial
"Stock Option award covering 1190.0000 underlying shares of common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price of 527.0700 applies to the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Annual non-employee director award financial
"Annual non-employee director award describes the RSU and option grants"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity awards did United Therapeutics (UTHR) grant to director Linda Maxwell?
United Therapeutics granted Linda Maxwell 380 restricted stock units and 1,190 stock options as annual non-employee director awards. The options are exercisable for common stock at $527.0700 per share, alongside RSUs that each convert into one share upon vesting.
When do Linda Maxwell’s new United Therapeutics (UTHR) equity awards vest?
The awards vest fully on the earlier of one year from the July 22, 2026 grant or the next Annual Meeting. The anticipated next Annual Meeting of Shareholders is on June 25, 2027, which would accelerate vesting if it occurs before the one-year anniversary.
What are the key terms of Linda Maxwell’s United Therapeutics (UTHR) stock options?
Maxwell received options on 1,190 shares of United Therapeutics common stock with a $527.0700 exercise price. These options vest on the same schedule as her RSUs and are scheduled to expire on July 22, 2033 if not exercised earlier.
How do Linda Maxwell’s United Therapeutics (UTHR) restricted stock units work?
Each of Maxwell’s 380 restricted stock units represents the right to receive one share of United Therapeutics common stock after vesting. The RSUs have no expiration date; they are tied to the vesting schedule linked to the one-year anniversary or Annual Meeting.
Were Linda Maxwell’s United Therapeutics (UTHR) equity awards under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked, indicating these equity awards were not made under a pre-arranged 10b5-1 trading plan. They are characterized as annual non-employee director compensation grants rather than trades executed under such a plan.